Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 965 of 1,261

  1. US 7939639

    Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2011 · Expires May 5, 2031

    granted

  2. US 7939689

    Short-acting sedative hypnotic agents for anesthesia and sedation

    Theravance, Inc. · Granted May 10, 2011 · Expires May 5, 2031

    granted

  3. US 7937889

    Green garlic and methods of production

    Ophios, LLC · Granted May 10, 2011 · Expires May 5, 2031

    granted

  4. US 7935721

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  5. US 7935351

    Use of CPG oligodeoxynucleotides to induce angiogenesis

    The United States of America, as represented by the Department of Health and Human Services · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  6. US 7935357

    Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

    The Regents of the University of California · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  7. US 7935796

    Monoclonal antibodies against ANGPTL3

    LEXICON PHARMACEUTICALS, INC. · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  8. US 7935714

    Compositions for sleeping disorders

    Bright Future Pharmaceutical Laboratories · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  9. US 7935693

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  10. CA 2708489

    UTILISATION ANTITUMORALE NOUVELLE DU CABAZITAXEL

    AVENTIS PHARMA SA [FR] · Granted Apr 29, 2011 · Expires Apr 24, 2031

    granted

  11. US 7932289

    Remedy for diabetes

    Takeda Pharmaceutical Company Limited · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted

  12. US 7932382

    Conformationally constrained Smac mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted

  13. US 7931640

    Method for muscle delivery of drugs, nucleic acids and other compounds

    Inovio AS · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted

  14. US 7931919

    Method of producing glycine-stabilized, lyophilized plasma

    The United States of America as represented by the Secretary of the Army · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted

  15. US 7932074

    Multivalent human-bovine rotavirus vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted

  16. US 7932052

    Use of methanobactin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted

  17. US 7932096

    Trioxyethylene gold nanoclusters functionalized with a single DNA

    United States of America as represented by the Secretary of the Air Force · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted

  18. US 7928138

    Marine actinomycete taxon for drug and fermentation product discovery

    The Regents of the University of California · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  19. US 7927583

    Receptor based antagonists and methods of making and using

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  20. US 7928244

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Infinity Discovery, Inc. · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  21. US 7928213

    Nucleic acids encoding chimeric CD154 polypeptides

    The Regents of the University of California · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  22. US 7928194

    Recombinant antigen for diagnosis and prevention of murine typhus

    United States of America as represented by the Secretary of the Air Force · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  23. US 7927833

    Composition and method for enhancing immune response

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  24. US 7928079

    Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.